Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP548809.RAMLW5TJ0O5e1lvWh4L0H_BMF-nXghv9H2uf0GzhUhDK0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP548809.RAMLW5TJ0O5e1lvWh4L0H_BMF-nXghv9H2uf0GzhUhDK0130_assertion type Assertion NP548809.RAMLW5TJ0O5e1lvWh4L0H_BMF-nXghv9H2uf0GzhUhDK0130_head.
- NP548809.RAMLW5TJ0O5e1lvWh4L0H_BMF-nXghv9H2uf0GzhUhDK0130_assertion description "[Thus, recombinant SP-D has been proposed as a therapeutical option for cystic fibrosis, neonatal lung disease and smoking-induced emphysema.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP548809.RAMLW5TJ0O5e1lvWh4L0H_BMF-nXghv9H2uf0GzhUhDK0130_provenance.
- NP548809.RAMLW5TJ0O5e1lvWh4L0H_BMF-nXghv9H2uf0GzhUhDK0130_assertion evidence source_evidence_literature NP548809.RAMLW5TJ0O5e1lvWh4L0H_BMF-nXghv9H2uf0GzhUhDK0130_provenance.
- NP548809.RAMLW5TJ0O5e1lvWh4L0H_BMF-nXghv9H2uf0GzhUhDK0130_assertion SIO_000772 16684127 NP548809.RAMLW5TJ0O5e1lvWh4L0H_BMF-nXghv9H2uf0GzhUhDK0130_provenance.
- NP548809.RAMLW5TJ0O5e1lvWh4L0H_BMF-nXghv9H2uf0GzhUhDK0130_assertion wasDerivedFrom befree-2016 NP548809.RAMLW5TJ0O5e1lvWh4L0H_BMF-nXghv9H2uf0GzhUhDK0130_provenance.
- NP548809.RAMLW5TJ0O5e1lvWh4L0H_BMF-nXghv9H2uf0GzhUhDK0130_assertion wasGeneratedBy ECO_0000203 NP548809.RAMLW5TJ0O5e1lvWh4L0H_BMF-nXghv9H2uf0GzhUhDK0130_provenance.